Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core

临床确定、生物样本采集、数据管理和分析研究核心

基本信息

  • 批准号:
    10262868
  • 负责人:
  • 金额:
    $ 42.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-04 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

CORE B ABSTRACT - Clinical Ascertainment, Retention and Biospecimen Acquisition Research Core The purpose of this core is to develop and support the two human birth cohorts which serve as the study populations to address fundamental questions about the role of respiratory syncytial virus (RSV) on childhood respiratory morbidity and asthma through scientific projects that focus on interactive pathways of the host and virus on asthma development (Project 1), and interventions that may modify immune and airway epithelial cell development through which RSV may cause asthma (Project 2). This clinical ascertainment, retention and biosample acquisition and management research core will serve to manage the two human study populations: Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure (INSPIRE) and Childhood Allergy and the Neonatal Environment (CANOE), and manage the resultant key biospecimens and data. Data acquisition will include careful phenotyping, RSV exposure assessment, physiologic testing, nasal airway epithelial cell (NAEC) collection, nasal brushings, blood and peripheral blood mononuclear cells (PBMCs), and DNA for Projects 1 and 2. This core is centered around the rich infrastructure at Vanderbilt and surrounding engaged pediatric and obstetrical clinics to conduct the clinical studies. This includes support for the recruitment, enrollment and retention of the birth cohorts, longitudinal follow-up, and the laboratory components of the biosample collection and processing. This core assembles a complementary research team of epidemiologists, virologists, immunologists, geneticists, biostatisticians, and research personnel experienced in cohort retention, and biospecimen acquisition and will provide the data and biospecimens to analytic Core C where data will be processed and biostatistical analyses will be conducted. This core is structured as two aims with each supporting one of the two cohorts. The first is to facilitate and oversee the longitudinal follow-up of the established INSPIRE birth cohort, biospecimen collection, including NAECs for Projects 1 and 2. The second is to facilitate and oversee recruitment, enrollment and longitudinal follow-up of the new CANOE birth cohort, and biospecimen collection, including NAECs for Projects 1 and 2.
核心B摘要-临床确认、保留和生物样本采集研究核心 该核心的目的是发展和支持两个人类出生队列, 研究人群,以解决有关呼吸道合胞病毒(RSV)在 儿童呼吸道疾病和哮喘通过科学项目,重点是互动的途径, 宿主和病毒对哮喘发展的影响(项目1),以及可能改变免疫和气道的干预措施 上皮细胞发育,RSV可通过上皮细胞发育引起哮喘(项目2)。临床确认, 保留和生物样本采集和管理研究核心将用于管理两项人类研究 人群:RSV暴露后婴儿对肺部感染和哮喘的易感性(INSPIRE)和 儿童过敏和新生儿环境(CANOE),并管理由此产生的关键生物标本, 数据数据采集将包括仔细的表型分型、RSV暴露评估、生理学测试、鼻内窥镜检查、呼吸道感染、呼吸道感染和呼吸道感染。 气道上皮细胞(NAEC)采集、鼻刷、血液和外周血单核细胞 (PBMC),以及项目1和2的DNA。 该核心以范德比尔特丰富的基础设施和周围参与儿科为中心 和产科诊所进行临床研究。这包括对招聘、注册和 保留出生队列、纵向随访和生物样本采集的实验室组成部分 和处理这个核心汇集了一个由流行病学家、病毒学家、 免疫学家、遗传学家、生物统计学家和具有队列保留经验的研究人员,以及 生物标本采集,并将数据和生物标本提供给分析核心C, 将进行处理和生物统计分析。这个核心由两个目标组成,每个目标 支持两支队伍中的一支第一是促进和监督《公约》的纵向后续行动, 建立INSPIRE出生队列,收集生物标本,包括项目1和2的NAEC。二是 促进和监督新CANOE出生队列的招募、入组和纵向随访,以及 生物标本采集,包括项目1和2的NAEC。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tina V Hartert其他文献

Tina V Hartert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tina V Hartert', 18)}}的其他基金

ECHO Renewal for the CANOE Study Cohort
CANOE 研究队列的 ECHO 更新
  • 批准号:
    10745082
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    10230392
  • 财政年份:
    2020
  • 资助金额:
    $ 42.64万
  • 项目类别:
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    10301922
  • 财政年份:
    2020
  • 资助金额:
    $ 42.64万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9090671
  • 财政年份:
    2016
  • 资助金额:
    $ 42.64万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9250797
  • 财政年份:
    2016
  • 资助金额:
    $ 42.64万
  • 项目类别:
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core
临床确定、生物样本采集、数据管理和分析研究核心
  • 批准号:
    10460524
  • 财政年份:
    2011
  • 资助金额:
    $ 42.64万
  • 项目类别:
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    9975086
  • 财政年份:
    2011
  • 资助金额:
    $ 42.64万
  • 项目类别:
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core
RSV 与哮喘合作临床确定和生物样本研究核心
  • 批准号:
    8196536
  • 财政年份:
    2011
  • 资助金额:
    $ 42.64万
  • 项目类别:
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core
临床确定、生物样本采集、数据管理和分析研究核心
  • 批准号:
    10675721
  • 财政年份:
    2011
  • 资助金额:
    $ 42.64万
  • 项目类别:
RSV and asthma: Defining host and exposure variation on disease development
RSV 和哮喘:定义疾病发展的宿主和暴露变异
  • 批准号:
    10460527
  • 财政年份:
    2011
  • 资助金额:
    $ 42.64万
  • 项目类别:

相似海外基金

Neurolinguistic development in 4 to 8 year-old late talkers with language delay
语言迟缓的 4 至 8 岁说话晚者的神经语言发育
  • 批准号:
    10539603
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
The effect of in-utero exposure to metformin in 5-8 year old offspring of mothers in the MiTy Trial (MiTy Tykes)
MiTy 试验 (MiTy Tykes) 中子宫内暴露于二甲双胍对母亲 5-8 岁后代的影响
  • 批准号:
    432867
  • 财政年份:
    2020
  • 资助金额:
    $ 42.64万
  • 项目类别:
    Operating Grants
Bone strength in 8 year old children: influence of preg nancy, early childhood and current lifestyle factor
8 岁儿童的骨强度:怀孕、幼儿期和当前生活方式因素的影响
  • 批准号:
    nhmrc : 961030
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了